Podcast 593: TXA for GIB
Sep 07, 2020•2 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Contributor: Ricky Dhaliwal, MD, JD
Educational Pearls:
- Tranexamic acid (TXA) as shown to have mortality benefit to patients with traumatic GI hemorrhage but should it be used to achieve hemostasis in atraumatic GI bleeding?
- HALT-IT study looked at TXA for the treatment of upper and lower GI hemorrhage and found no 5 day mortality benefit
- Patients given TXA also had higher occurrences of DVT and PE
References
Roberts I, Coats T, Edwards P, et al. HALT-IT--tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial. Trials. 2014;15:450. Published 2014 Nov 19. doi:10.1186/1745-6215-15-450
Summarized by Jackson Roos, MS4 | Edited by Erik Verzemnieks, MD
For the best experience, listen in Metacast app for iOS or Android